Dr. Mark Mattar, MD

NPI: 1841401031
Total Payments
$385,054
2024 Payments
$61,692
Companies
16
Transactions
365
Medicare Patients
1,024
Medicare Billing
$152,448

Payment Breakdown by Category

Other$317,135 (82.4%)
Consulting$43,938 (11.4%)
Travel$14,276 (3.7%)
Food & Beverage$9,446 (2.5%)
Education$259.05 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $317,135 129 82.4%
Consulting Fee $43,938 18 11.4%
Travel and Lodging $14,276 78 3.7%
Food and Beverage $9,446 134 2.5%
Education $259.05 6 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $153,631 151 $0 (2024)
E.R. Squibb & Sons, L.L.C. $65,777 33 $0 (2024)
PFIZER INC. $40,108 27 $0 (2023)
Janssen Biotech, Inc. $37,561 48 $0 (2024)
Janssen Scientific Affairs, LLC $33,083 35 $0 (2024)
Lilly USA, LLC $20,064 28 $0 (2024)
Daiichi Sankyo Inc. $14,124 12 $0 (2017)
Takeda Pharmaceuticals U.S.A., Inc. $9,202 6 $0 (2022)
Celltrion USA Inc. $5,478 8 $0 (2024)
Janssen Global Services, LLC $4,200 2 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $61,692 53 Janssen Biotech, Inc. ($23,932)
2023 $51,503 49 ABBVIE INC. ($17,351)
2022 $41,501 33 Janssen Scientific Affairs, LLC ($13,701)
2021 $59,794 37 E.R. Squibb & Sons, L.L.C. ($30,928)
2020 $28,585 33 AbbVie Inc. ($19,905)
2019 $44,194 40 AbbVie, Inc. ($25,908)
2018 $61,860 63 AbbVie, Inc. ($49,161)
2017 $35,925 57 AbbVie, Inc. ($15,497)

All Payment Transactions

365 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/30/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $554.00 General
12/19/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $7,199.00 General
12/16/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: IMMUNOLOGY
12/11/2024 Celltrion USA Inc. ZYMFENTRA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $277.50 General
Category: GASTROENTEROLOGY
12/02/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: IMMUNOLOGY
11/14/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $122.92 General
Category: IMMUNOLOGY
10/31/2024 Celltrion USA Inc. ZYMFENTRA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,110.00 General
Category: GASTROENTEROLOGY
10/29/2024 Janssen Biotech, Inc. STELARA (Biological), TREMFYA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,250.00 General
Category: Immunology
10/28/2024 ABBVIE INC. SKYRIZI (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: IMMUNOLOGY
10/26/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: Immunology
10/25/2024 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,104.50 General
Category: Neuroscience
10/21/2024 Janssen Biotech, Inc. STELARA (Biological), TREMFYA Travel and Lodging Cash or cash equivalent $53.00 General
Category: Immunology
10/21/2024 Janssen Biotech, Inc. STELARA (Biological), TREMFYA Food and Beverage Cash or cash equivalent $16.49 General
Category: Immunology
10/19/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: Immunology
10/19/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: Immunology
10/14/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Travel and Lodging Cash or cash equivalent $63.65 General
Category: Immunology
10/14/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Travel and Lodging Cash or cash equivalent $55.05 General
Category: Immunology
10/12/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,375.00 General
Category: Immunology
10/12/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,500.00 General
Category: Immunology
10/10/2024 Celltrion USA Inc. ZYMFENTRA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,110.00 General
Category: GASTROENTEROLOGY
10/08/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $125.00 General
Category: Immunology
09/28/2024 Janssen Biotech, Inc. STELARA (Biological), TREMFYA Food and Beverage In-kind items and services $59.33 General
Category: Immunology
09/28/2024 Janssen Biotech, Inc. STELARA (Biological), TREMFYA Food and Beverage In-kind items and services $38.93 General
Category: Immunology
09/28/2024 Janssen Biotech, Inc. STELARA (Biological), TREMFYA Food and Beverage In-kind items and services $38.15 General
Category: Immunology
09/27/2024 Janssen Biotech, Inc. STELARA (Biological), TREMFYA Travel and Lodging In-kind items and services $318.31 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 241 261 $172,028 $36,243
2022 9 295 313 $198,155 $46,760
2021 8 277 290 $177,918 $41,841
2020 9 211 224 $113,151 $27,604
Total Patients
1,024
Total Services
1,088
Medicare Billing
$152,448
Procedure Codes
34

All Medicare Procedures & Services

34 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 78 97 $38,068 $13,871 36.4%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 48 48 $52,272 $6,483 12.4%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 21 21 $16,191 $4,013 24.8%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 23 24 $11,664 $3,556 30.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 15 15 $7,785 $2,582 33.2%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 30 30 $30,956 $2,344 7.6%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 11 11 $10,032 $1,795 17.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 15 15 $5,060 $1,599 31.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 75 89 $31,417 $13,068 41.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 60 62 $67,518 $8,253 12.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 35 36 $17,489 $6,241 35.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 29 29 $14,587 $5,381 36.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 21 21 $15,855 $4,842 30.5%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 34 35 $35,315 $2,985 8.5%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 12 12 $5,964 $2,550 42.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 18 18 $7,260 $2,433 33.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 11 11 $2,750 $1,007 36.6%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 74 86 $30,358 $13,583 44.7%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 59 59 $64,251 $7,692 12.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 36 36 $17,489 $6,278 35.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 31 31 $12,431 $4,415 35.5%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 13 13 $9,815 $2,898 29.5%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 31 31 $31,279 $2,599 8.3%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 15 15 $7,545 $2,593 34.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 18 19 $4,750 $1,783 37.5%

About Dr. Mark Mattar, MD

Dr. Mark Mattar, MD is a Gastroenterology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841401031.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mattar, MD has received a total of $385,054 in payments from pharmaceutical and medical device companies, with $61,692 received in 2024. These payments were reported across 365 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($317,135).

As a Medicare-enrolled provider, Mattar has provided services to 1,024 Medicare beneficiaries, totaling 1,088 services with total Medicare billing of $152,448. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology, Gastroenterology
  • Location Washington, DC
  • Active Since 05/27/2007
  • Last Updated 01/17/2019
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1841401031

Products in Payments

  • Humira (Biological) $60,817
  • ZEPOSIA (Drug) $58,093
  • STELARA (Biological) $53,909
  • XELJANZ (Drug) $40,040
  • HUMIRA (Biological) $29,553
  • SKYRIZI (Biological) $16,834
  • RINVOQ (Biological) $16,679
  • TREMFYA (Drug) $16,636
  • INJECTAFER (Drug) $14,124
  • OMVOH (Drug) $11,092
  • ENTYVIO (Biological) $9,202
  • ZYMFENTRA (Biological) $5,478
  • REMICADE (Biological) $99.00
  • Vemlidy (Drug) $96.83
  • VOWST (Biological) $47.25
  • Cimzia (Drug) $43.10
  • GED-0301 (Drug) $17.00
  • GENERAL POLYPECTOMY (Device) $14.86
  • EXALT Model D (Device) $13.17
  • Ozanimod (Drug) $12.19

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Washington